表紙
市場調查報告書
商品編碼
1030583

體外診斷用醫藥品(IVD)市場:各產品類型、技術、用途、終端用戶 - 機會分析與產業預測(2021年∼2030年)

In Vitro Diagnostics Market by Product Type, Technique, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021 - 2030

出版日期: | 出版商: Next Move Strategy Consulting | 英文 690 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

市場定義

全球體外診斷用醫藥品(IVD)市場,2020年估計為796億8,000萬美元以上,從2021年到2030年預計以4.5%的年複合成長率成長,達1,185億7,000萬美元以上。體外診斷用醫藥品(IVD),是為了查出疾病和感染疾病的檢驗。使用從人體採集的組織和血液等樣本進行。體外診斷用醫藥品(IVD),由於對感染疾病,心臟疾病,癌症,腎臟疾病等,各種病情的診斷有效,在醫療保健領域受到很大關注。

市場動態與趨勢

隨著感染疾病和慢性疾病增加,全球體外診斷用醫藥品(IVD)數持續增加,促進體外診斷用醫藥品(IVD)市場成長。還有容易患免疫疾病的老年人口增加,也推動這個市場成長。可是,體外診斷用醫藥品(IVD)相關政府的嚴格法規和不利的補償政策妨礙市場成長。同時,開發中國家的人口增加和體外診斷用醫藥品(IVD)的普及,預期在預測期間內帶給市場有利的機會。

目錄

第1章 簡介

第2章 體外診斷用醫藥品(IVD)市場 - 摘要整理

  • 市場概述(2019年∼2030年)

第3章 市場佔有率分析(2020年)

第4章 市場概要

  • 市場定義和範圍
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會

第5章 新型冠狀病毒感染疾病(COVID-19)分析

第6章 全球體外診斷用醫藥品(IVD)市場:各產品類型

  • 概要
  • 試劑
  • 設備
  • 軟體、服務

第7章 全球體外診斷用醫藥品(IVD)市場:各技術

  • 概要
  • 免疫診斷
  • 血液學
  • 分子診斷
  • 組織診斷
  • 臨床化學
  • 其他

第8章 全球體外診斷用醫藥品(IVD)市場:各用途

  • 概要
  • 感染疾病
  • 癌症
  • 心臟病
  • 免疫系疾病
  • 腎臟疾病
  • 腸胃疾病
  • 其他

第9章 全球體外診斷用醫藥品(IVD)市場:各終端用戶

  • 概要
  • 獨立型實驗室
  • 醫院
  • 學術機構、醫學校
  • 就地檢驗
  • 其他

第10章 全球體外診斷用醫藥品(IVD)市場:各地區

  • 概要
  • 北美
    • 北美的體外診斷用醫藥品(IVD)市場:各產品類型
    • 北美的體外診斷用醫藥品(IVD)市場:各技術
    • 北美的體外診斷用醫藥品(IVD)市場:各用途
    • 北美的體外診斷用醫藥品(IVD)市場:各終端用戶
    • 北美的體外診斷用醫藥品(IVD)市場:各國
  • 歐洲
  • 亞太地區
  • 其他地區

第11章 企業簡介

  • BIOMERIEUX
  • SYSMEX CORPORATION
  • QIAGEN N.V.
  • BIO-RAD LABORATORIES, INC.
  • BECTON, DICKINSON AND COMPANY
  • ROCHE HOLDING
  • ABBOTT
  • DANAHER
  • SIEMENS HEALTHINEERS
  • THERMO FISHER SCIENTIFIC INC.
目錄

Market Definition:

At an estimated value of over USD 79.68 billion in 2020, the Global In Vitro Diagnostics (IVD) Market is predicted to thrive at a CAGR of 4.5% and valued at over USD 118.57 billion over the forecast year 2021-2030. In vitro diagnostics (IVD) are the tests for detecting disease and infections. It is done on samples such as tissue or blood taken from the human body. There are several types of in vitro diagnostic instruments that offers features such as tissue diagnostics, hematology, immunodiagnostics, and molecular diagnostics. The in vitro diagnostics is experiencing a significant popularity in healthcare sector due to its efficacy in diagnosing numerous medical conditions such as infectious diseases, cardiac disorders, cancer, and nephrological disorders.

Market Dynamics and Trends

Upsurge in number of in vitro diagnostic tests across the globe owing to the increased incidences of infectious and chronic diseases drives the growth of IVD market. In addition, rise in geriatric population, which is vulnerable to immunological disorders have been pushing the growth of the market globally. However, strict government regulations related to the in-vitro diagnostics along with unfavorable compensation policies hamper the growth of the market. On the other hand, high growth shown by the developing countries in terms of population & proliferation of in vitro diagnostic tests is expected to create lucrative opportunities to further propel market growth throughout the forecast period.

Market Segmentations and Scope of the Study:

The global In vitro diagnostics (IVD) market share is segmented on the basis of product & service, technique, application, end user, and geography. On the basis of product & service, the market is categorized into Instruments, Reagents, and Software & Services. According to the technique, the market is segmented into immunodiagnostics, hematology, molecular diagnostics, clinical chemistry, tissue diagnostics, and others. As per the application, the market is divided into infectious diseases, cancer, immune system disorders, cardiac diseases, nephrological diseases, gastrointestinal diseases, and others. On the basis of end user, the market is segmented into standalone laboratory, academic & medical schools, hospitals, point of care, and others. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.

Geographical Analysis

In terms of geography, North America held major share of the market in 2019. This is attributed to the well-established healthcare system and the healthcare related awareness among people across the region. However, Asia-pacific is expected to witness highest growth rate during the forecast period, due to the surge in healthcare expenditure and rise in prevalence of diabetes in the region. Moreover, massively growing patient base of chronic diseases in the region that require IVD testing is projected to be opportunistic for the market growth.

Competitive Landscape

Lucrative growth opportunities make the In Vitro Diagnostics (IVD) market highly competitive. Some of the major players in the market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, BioMerieux SA, Sysmex Corporation, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Thermo Fisher Scientific, Inc. and many more. A number of developmental strategies have been adopted by companies in the past few years. For instance, in October 2020, Quanterix Corporation entered into a non-exclusive royalty-bearing license agreement with Abbott Laboratories. This agreement grants Abbott an access to Quanterix' portfolio of bead-based technology patents for the use in in vitro diagnostic (IVD) applications.

Moreover, in March 2019, Becton, Dickinson and Company announced the CE-IVD certification for the BD FACSDuet automated flow cytometry system. This will enable clinical laboratories to enhance their efficiency by reducing errors as well as limiting the manual user interactions that are required to run assays on the BD FACSLyric clinical flow cytometer.

KEY MARKET SEGMENTS:

Global In Vitro Diagnostics (IVD) Market- By Product Type

  • Instruments
  • Reagents
  • Software & Services

Global In Vitro Diagnostics (IVD) Market - By Technique

  • Immunodiagnostics
    • Enzyme-linked immunosorbent assay (ELISA)
    • Rapid Tests
    • Enzyme-linked immunospot (ELISPOT)
    • Radioimmunoassay (RIA)
    • Western blot
    • Hematology
    • Molecular Diagnostics
    • Polymerize chain reaction (PCR)
    • Isothermal Nucleic acid amplification technology (INAAT)
    • Hybridization
    • DNA diagnostics
    • Microarray
    • Others
  • Clinical Chemistry
    • Basic metabolic panel
    • Liver panel
    • Renal profile
    • Lipid profile
    • Thyroid function panel
    • Electrolyte panel
    • Specialty chemicals
    • Tissue Diagnostics
    • Others

Global In Vitro Diagnostics (IVD) Market - By Application

  • Infectious Diseases
  • Cancer
  • Immune System Disorders
  • Cardiac Diseases
  • Nephrological Diseases
  • Gastrointestinal Diseases
  • Others

Global In Vitro Diagnostics (IVD) Market - By End User

  • Standalone Laboratory
  • Academic & Medical Schools
  • Hospitals
  • Point of Care
  • Others

Global In Vitro Diagnostics (IVD) Market - By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • RoW
    • Latin America
    • Middle East
    • Africa

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. WHO SHOULD READ THIS REPORT
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1 SECONDARY RESEARCH
    • 1.4.2 DATA ANALYSIS FRAMEWORK
    • 1.4.3 MARKET SIZE ESTIMATION
    • 1.4.4 FORECASTING
    • 1.4.5 PRIMARY RESEARCH AND DATA VALIDATION

2. IN VITRO DIAGNOSTICS (IVD) MARKET - EXECUTIVE SUMMARY

  • 2.1. MARKET SNAPSHOT, 2019 - 2030, MILLION USD

3. MARKET SHARE ANALYSIS, 2020 (%)

4. MARKET OVERVIEW

  • 4.1. MARKET DEFINITION AND SCOPE
  • 4.2. MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1. Rising incidences of chronic and infectious diseases
      • 4.2.1.2. Technological advancements in IVD
      • 4.2.1.3. Increasing Use of minimally invasive techniques
      • 4.2.1.4. Adoption of Personalized medicine approach
    • 4.2.2 RESTRAINTS
      • 4.2.2.1. Lack of reimbursement policies
      • 4.2.2.1 Stringent regulatory policies
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1. Potential opportunities for outsourcing
      • 4.2.3.1 Evolution in the technologies

5. COVID-19 ANALYSIS

6. GLOBAL IN VITRO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE

  • 6.1. OVERVIEW
  • 6.2. REAGENTS
    • 6.2.1 REAGENTS MARKET, BY REGION
      • 6.2.1.1 North America Reagents market, By Country
      • 6.2.1.2 Europe Reagents market, By Country
      • 6.2.1.3 Asia-Pacific Reagents market, By Country
      • 6.2.1.4 Rest of World Reagents market, By Country
  • 6.3. INSTRUMENTS
    • 6.3.1 INSTRUMENTS MARKET, BY REGION
      • 6.3.1.1 North America Instruments market, By Country
      • 6.3.1.2 Europe Instruments market, By Country
      • 6.3.1.3 Asia-Pacific Instruments market, By Country
      • 6.3.1.4 Rest of World Instruments market, By Country
  • 6.4. SOFTWARE AND SERVICES
    • 6.4.1 SOFTWARE AND SERVICES MARKET, BY REGION
      • 6.4.1.1 North America Software and Services market, By Country
      • 6.4.1.2 Europe Software and Services market, By Country
      • 6.4.1.3 Asia-Pacific Software and Services market, By Country
      • 6.4.1.4 Rest of World Software and Services market, By Country

7. GLOBAL IN VITRO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE

  • 7.1. OVERVIEW
  • 7.2. IMMUNODIAGNOSTICS
    • 7.2.1 GLOBAL IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
      • 7.2.1.1 ELISA Market, By Region
        • 7.2.1.1.1 North America ELISA Market, By Country
        • 7.2.1.1.2 Europe ELISA Market, By Country
        • 7.2.1.1.3 Asia-Pacific ELISA Market, By Country
        • 7.2.1.1.4 Rest of World ELISA Market, By Country
      • 7.2.1.2 Rapid Tests Market, By Region
        • 7.2.1.2.1 North America Rapid Tests Market, By Country
        • 7.2.1.2.2 Europe Rapid Tests Market, By Country
        • 7.2.1.2.3 Asia-Pacific Rapid Tests Market, By Country
        • 7.2.1.2.4 Rest of World Rapid Tests Market, By Country
      • 7.2.1.3 ELISPOT Market, By Region
        • 7.2.1.3.1 North America ELISPOT Market, By Country
        • 7.2.1.3.2 Europe ELISPOT Market, By Country
        • 7.2.1.3.3 Asia-Pacific ELISPOT Market, By Country
        • 7.2.1.3.4 Rest of World ELISPOT Market, By Country
      • 7.2.1.4 Radioimmunoassay (RIA) Market, By Region
        • 7.2.1.4.1 North America Radioimmunoassay (RIA) Market, By Country
        • 7.2.1.4.2 Europe Radioimmunoassay (RIA) Market, By Country
        • 7.2.1.4.3 Asia-Pacific Radioimmunoassay (RIA) Market, By Country
        • 7.2.1.4.4 Rest of World Radioimmunoassay (RIA) Market, By Country
      • 7.2.1.5 Western Blot Market, By Region
        • 7.2.1.5.1 North America Western Blot Market, By Country
        • 7.2.1.5.2 Europe Western Blot Market, By Country
        • 7.2.1.5.3 Asia-Pacific Western Blot Market, By Country
        • 7.2.1.5.4 Rest of World Western Blot Market, By Country
    • 7.2.2 IMMUNODIAGNOSTICS MARKET, BY REGION
      • 7.2.2.1 North America Immunodiagnostics Market, By Country
      • 7.2.2.2 Europe Immunodiagnostics Market, By Country
      • 7.2.2.3 Asia-Pacific Immunodiagnostics Market, By Country
      • 7.2.2.4 Rest of World Immunodiagnostics Market, By Country
  • 7.3. HEMATOLOGY
    • 7.3.1 HEMATOLOGY MARKET, BY REGION
      • 7.3.1.1 North America Hematology Market, By Country
      • 7.3.1.2 Europe Hematology Market, By Country
      • 7.3.1.3 Asia-Pacific Hematology Market, By Country
      • 7.3.1.4 Rest of World Hematology Market, By Country
  • 7.4. MOLECULAR DIAGNOSTICS
    • 7.4.1 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
      • 7.4.1.1 PCR Market, By Region
        • 7.4.1.1.1 North America PCR Market, By Country
        • 7.4.1.1.2 Europe PCR Market, By Country
        • 7.4.1.1.3 Asia-Pacific PCR Market, By Country
        • 7.4.1.1.4 Rest of World PCR Market, By Country
      • 7.4.1.2 INAAT Market, By Region
        • 7.4.1.2.1 North America INAAT Market, By Country
        • 7.4.1.2.2 Europe INAAT Market, By Country
        • 7.4.1.2.3 Asia-Pacific INAAT Market, By Country
        • 7.4.1.2.4 Rest of World INAAT Market, By Country
      • 7.4.1.3 Hybridization Market, By Region
        • 7.4.1.3.1 North America Hybridization Market, By Country
        • 7.4.1.3.2 Europe Hybridization Market, By Country
        • 7.4.1.3.3 Asia-Pacific Hybridization Market, By Country
        • 7.4.1.3.4 Rest of World Hybridization Market, By Country
      • 7.4.1.4 DNA diagnostics Market, By Region
        • 7.4.1.4.1 North America DNA diagnostics Market, By Country
        • 7.4.1.4.2 Europe DNA diagnostics Market, By Country
        • 7.4.1.4.3 Asia-Pacific DNA diagnostics Market, By Country
        • 7.4.1.4.4 Rest of World DNA diagnostics Market, By Country
      • 7.4.1.5 Microarray Market, By Region
        • 7.4.1.5.1 North America Microarray Market, By Country
        • 7.4.1.5.2 Europe Microarray Market, By Country
        • 7.4.1.5.3 Asia-Pacific Microarray Market, By Country
        • 7.4.1.5.4 Rest of World Microarray Market, By Country
      • 7.4.1.6 Others market, By Region
        • 7.4.1.6.1 North America Others market, By Country
        • 7.4.1.6.2 Europe Others market, By Country
        • 7.4.1.6.3 Asia-Pacific Others market, By Country
        • 7.4.1.6.4 Rest of World Others market, By Country
    • 7.4.2 MOLECULAR DIAGNOSTICS MARKET, BY REGION
      • 7.4.2.1 North America Molecular Diagnostics Market, By Country
      • 7.4.2.2 Europe Molecular Diagnostics Market, By Country
      • 7.4.2.3 Asia-Pacific Molecular Diagnostics Market, By Country
      • 7.4.2.4 Rest of World Molecular Diagnostics Market, By Country
  • 7.5. TISSUE DISGNOSTICS
    • 7.5.1 TISSUE DISGNOSTICS MARKET, BY REGION
      • 7.5.1.1 North America Tissue Disgnostics Market, By Country
      • 7.5.1.2 Europe Tissue Disgnostics Market, By Country
      • 7.5.1.3 Asia-Pacific Tissue Disgnostics Market, By Country
      • 7.5.1.4 Rest of World Tissue Disgnostics Market, By Country
  • 7.6. CLINICAL CHEMISTRY
    • 7.6.1 GLOBAL CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
      • 7.6.1.1 Basic Metabolic Panel Market, By Region
        • 7.6.1.1.1 North America Basic Metabolic Panel Market, By Country
        • 7.6.1.1.2 Europe Basic Metabolic Panel Market, By Country
        • 7.6.1.1.3 Asia-Pacific Basic Metabolic Panel Market, By Country
        • 7.6.1.1.4 Rest of World Basic Metabolic Panel Market, By Country
      • 7.6.1.2 Liver Panel Market, By Region
        • 7.6.1.2.1 North America Liver Panel Market, By Country
        • 7.6.1.2.2 Europe Liver Panel Market, By Country
        • 7.6.1.2.3 Asia-Pacific Liver Panel Market, By Country
        • 7.6.1.2.4 Rest of World Liver Panel Market, By Country
      • 7.6.1.3 Renal Profile Market, By Region
        • 7.6.1.3.1 North America Renal Profile Market, By Country
        • 7.6.1.3.2 Europe Renal Profile Market, By Country
        • 7.6.1.3.3 Asia-Pacific Renal Profile Market, By Country
        • 7.6.1.3.4 Rest of World Renal Profile Market, By Country
      • 7.6.1.4 Lipid Profile Market, By Region
        • 7.6.1.4.1 North America Lipid Profile Market, By Country
        • 7.6.1.4.2 Europe Lipid Profile Market, By Country
        • 7.6.1.4.3 Asia-Pacific Lipid Profile Market, By Country
        • 7.6.1.4.4 Rest of World Lipid Profile Market, By Country
      • 7.6.1.5 Thyroid Function Panel Market, By Region
        • 7.6.1.5.1 North America Thyroid Function Panel Market, By Country
        • 7.6.1.5.2 Europe Thyroid Function Panel Market, By Country
        • 7.6.1.5.3 Asia-Pacific Thyroid Function Panel Market, By Country
        • 7.6.1.5.4 Rest of World Thyroid Function Panel Market, By Country
      • 7.6.1.6 Electrolyte Panel Market, By Region
        • 7.6.1.6.1 North America Electrolyte Panel Market, By Country
        • 7.6.1.6.2 Europe Electrolyte Panel Market, By Country
        • 7.6.1.6.3 Asia-Pacific Electrolyte Panel Market, By Country
        • 7.6.1.6.4 Rest of World Electrolyte Panel Market, By Country
      • 7.6.1.7 Speciality Chemicals Market, By Region
        • 7.6.1.7.1 North America Speciality Chemicals Market, By Country
        • 7.6.1.7.2 Europe Speciality Chemicals Market, By Country
        • 7.6.1.7.3 Asia-Pacific Speciality Chemicals Market, By Country
        • 7.6.1.7.4 Rest of World Speciality Chemicals Market, By Country
    • 7.6.2 CLINICAL CHEMISTRY MARKET, BY REGION
      • 7.6.2.1 North America Clinical Chemistry Market, By Country
      • 7.6.2.2 Europe Clinical Chemistry Market, By Country
      • 7.6.2.3 Asia-Pacific Clinical Chemistry Market, By Country
      • 7.6.2.4 Rest of World Clinical Chemistry Market, By Country
  • 7.7. OTHER IVD TECHNIQUES
    • 7.7.1 OTHER IVD TECHNIQUES MARKET, BY REGION
      • 7.7.1.1 North America Other IVD Techniques Market, By Country
      • 7.7.1.2 Europe Other IVD Techniques Market, By Country
      • 7.7.1.3 Asia-Pacific Other IVD Techniques Market, By Country
      • 7.7.1.4 Rest of World Other IVD Techniques Market, By Country

8. GLOBAL IN VITRO DIAGNOSTIC (IVD) MARKET, BY APPLICATION

  • 8.1. OVERVIEW
  • 8.2. INFECTIOUS DISEASES
    • 8.2.1 INFECTIOUS DISEASES MARKET, BY REGION
      • 8.2.1.1 North America Infectious Diseases Market, By Country
      • 8.2.1.2 Europe Infectious Diseases Market, By Country
      • 8.2.1.3 Asia-Pacific Infectious Diseases Market, By Country
      • 8.2.1.4 Rest of World Infectious Diseases Market, By Country
  • 8.3. CANCER
    • 8.3.1 CANCER MARKET, BY REGION
      • 8.3.1.1 North America Cancer Market, By Country
      • 8.3.1.2 Europe Cancer Market, By Country
      • 8.3.1.3 Asia-Pacific Cancer Market, By Country
      • 8.3.1.4 Rest of World Cancer Market, By Country
  • 8.4. CARDIAC DISEASES
    • 8.4.1 CARDIAC DISEASES MARKET, BY REGION
      • 8.4.1.1 North America Cardiac Diseases Market, By Country
      • 8.4.1.2 Europe Cardiac Diseases Market, By Country
      • 8.4.1.3 Asia-Pacific Cardiac Diseases Market, By Country
      • 8.4.1.4 Rest of World Cardiac Diseases Market, By Country
  • 8.5. IMMUNE SYSTEM DISORDERS
    • 8.5.1 IMMUNE SYSTEM DISORDERS MARKET, BY REGION
      • 8.5.1.1 North America Immune System Disorders Market, By Country
      • 8.5.1.2 Europe Immune System Disorders Market, By Country
      • 8.5.1.3 Asia-Pacific Immune System Disorders Market, By Country
      • 8.5.1.4 Rest of World Immune System Disorders Market, By Country
  • 8.6. NEPHROLOGICAL DISEASES
    • 8.6.1 NEPHROLOGICAL DISEASES MARKET, BY REGION
      • 8.6.1.1 North America Nephrological Diseases Market, By Country
      • 8.6.1.2 Europe Nephrological Diseases Market, By Country
      • 8.6.1.3 Asia-Pacific Nephrological Diseases Market, By Country
      • 8.6.1.4 Rest of World Nephrological Diseases Market, By Country
  • 8.7. GASTROINTESTINAL DISEASES
    • 8.7.1 GASTROINTESTINAL DISEASES MARKET, BY REGION
      • 8.7.1.1 North America Gastrointestinal Diseases Market, By Country
      • 8.7.1.2 Europe Gastrointestinal Diseases Market, By Country
      • 8.7.1.3 Asia-Pacific Gastrointestinal Diseases Market, By Country
      • 8.7.1.4 Rest of World Gastrointestinal Diseases Market, By Country
  • 8.8. OTHER INDICATIONS
    • 8.8.1 OTHER INDICATIONS MARKET, BY REGION
      • 8.8.1.1 North America Other Indications Market, By Country
      • 8.8.1.2 Europe Other Indications Market, By Country
      • 8.8.1.3 Asia-Pacific Other Indications Market, By Country
      • 8.8.1.4 Rest of World Other Indications Market, By Country

9. GLOBAL IN VITRO DIAGNOSTIC (IVD) MARKET, BY ENDUSER

  • 9.1. OVERVIEW
  • 9.2. STAND ALONE LABORATORY
    • 9.2.1 STAND ALONE LABORATORY MARKET, BY REGION
      • 9.2.1.1 North America Stand Alone Laboratory Market, By Country
      • 9.2.1.2 Europe Stand Alone Laboratory Market, By Country
      • 9.2.1.3 Asia-Pacific Stand Alone Laboratory Market, By Country
      • 9.2.1.4 Rest of World Stand Alone Laboratory Market, By Country
  • 9.3. HOSPITALS
    • 9.3.1 HOSPITALS MARKET, BY REGION
      • 9.3.1.1 North America Hospitals Market, By Country
      • 9.3.1.2 Europe Hospitals Market, By Country
      • 9.3.1.3 Asia-Pacific Hospitals Market, By Country
      • 9.3.1.4 Rest of World Hospitals Market, By Country
  • 9.4. ACADEMICS AND MEDICAL SCHOOLS
    • 9.4.1 ACADEMICS AND MEDICAL SCHOOLS MARKET, BY REGION
      • 9.4.1.1 North America Academics and Medical Schools Market, By Country
      • 9.4.1.2 Europe Academics and Medical Schools Market, By Country
      • 9.4.1.3 Asia-Pacific Academics and Medical Schools Market, By Country
      • 9.4.1.4 Rest of World Academics and Medical Schools Market, By Country
  • 9.5. POINT OF CARE TESTING
    • 9.5.1 POINT OF CARE TESTING MARKET, BY REGION
      • 9.5.1.1 North America Point of Care Testing Market, By Country
      • 9.5.1.2 Europe Point of Care Testing Market, By Country
      • 9.5.1.3 Asia-Pacific Point of Care Testing Market, By Country
      • 9.5.1.4 Rest of World Point of Care Testing Market, By Country
  • 9.6. OTHERS
    • 9.6.1 OTHERS MARKET, BY REGION
      • 9.6.1.1 North America Others Market, By Country
      • 9.6.1.2 Europe Others Market, By Country
      • 9.6.1.3 Asia-Pacific Others Market, By Country
      • 9.6.1.4 Rest of World Others Market, By Country

10. GLOBAL IN VITRO DIAGNOSTIC (IVD) MARKET, BY REGION

  • 10.1. OVERVIEW
  • 10.2. NORTH AMERICA
    • 10.2.1 NORTH AMERICA IN VITRO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE
    • 10.2.2 NORTH AMERICA IN VITRO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE
      • 10.2.2.1 North America Immunodiagnostics Market, By Technique
      • 10.2.2.2 North America Molecular Diagnostics Market, By Technique
      • 10.2.2.3 North America Clinical Chemistry Market, By Technique
    • 10.2.3 NORTH AMERICA IN VITRO DIAGNOSTIC (IVD) MARKET, BY APPLICATION
    • 10.2.4 NORTH AMERICA IN VITRO DIAGNOSTIC (IVD) MARKET, BY ENDUSER
    • 10.2.5 NORTH AMERICA IN VITRO DIAGNOSTIC (IVD) MARKET, BY COUNTRY
      • 10.2.5.1 U.S.
        • 10.2.5.1.1 U.S. In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.2.5.1.2 U.S. In Vitro Diagnostic (IVD) Market, By Technique
        • 10.2.5.1.2.1. U.S. Immunodiagnostics Market, By Technique
        • 10.2.5.1.2.2. U.S. Molecular Diagnostics Market, By Technique
        • 10.2.5.1.2.3. U.S. Clinical Chemistry Market, By Technique
        • 10.2.5.1.3 U.S. In Vitro Diagnostic (IVD) Market, By Application
        • 10.2.5.1.4 U.S. In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.2.5.2 Canada
        • 10.2.5.2.1 Canada In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.2.5.2.2 Canada In Vitro Diagnostic (IVD) Market, By Technique
        • 10.2.5.2.2.1. Canada Immunodiagnostics Market, By Technique
        • 10.2.5.2.2.2. Canada Molecular Diagnostics Market, By Technique
        • 10.2.5.2.2.3. Canada Clinical Chemistry Market, By Technique
        • 10.2.5.2.3 Canada In Vitro Diagnostic (IVD) Market, By Application
        • 10.2.5.2.4 Canada In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.2.5.3 Mexico
        • 10.2.5.3.1 Mexico In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.2.5.3.2 Mexico In Vitro Diagnostic (IVD) Market, By Technique
        • 10.2.5.3.2.1. Mexico Immunodiagnostics Market, By Technique
        • 10.2.5.3.2.2. Mexico Molecular Diagnostics Market, By Technique
        • 10.2.5.3.2.3. Mexico Clinical Chemistry Market, By Technique
        • 10.2.5.3.3 Mexico In Vitro Diagnostic (IVD) Market, By Application
        • 10.2.5.3.4 Mexico In Vitro Diagnostic (IVD) Market, By Enduser
  • 10.3. EUROPE
    • 10.3.1 EUROPE IN VITRO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE
    • 10.3.2 EUROPE IN VITRO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE
      • 10.3.2.1 Europe Immunodiagnostics Market, By Technique
      • 10.3.2.2 Europe Molecular Diagnostics Market, By Technique
      • 10.3.2.3 Europe Clinical Chemistry Market, By Technique
    • 10.3.3 EUROPE IN VITRO DIAGNOSTIC (IVD) MARKET, BY APPLICATION
    • 10.3.4 EUROPE IN VITRO DIAGNOSTIC (IVD) MARKET, BY ENDUSER
    • 10.3.5 EUROPE IN VITRO DIAGNOSTIC (IVD) MARKET, BY COUNTRY
      • 10.3.5.1 Germany
        • 10.3.5.1.1 Germany In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.3.5.1.2 Germany In Vitro Diagnostic (IVD) Market, By Technique
        • 10.3.5.1.2.1. Germany Immunodiagnostics Market, By Technique
        • 10.3.5.1.2.2. Germany Molecular Diagnostics Market, By Technique
        • 10.3.5.1.2.3. Germany Clinical Chemistry Market, By Technique
        • 10.3.5.1.3 Germany In Vitro Diagnostic (IVD) Market, By Application
        • 10.3.5.1.4 Germany In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.3.5.2 France
        • 10.3.5.2.1 France In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.3.5.2.2 France In Vitro Diagnostic (IVD) Market, By Technique
        • 10.3.5.2.2.1. France Immunodiagnostics Market, By Technique
        • 10.3.5.2.2.2. France Molecular Diagnostics Market, By Technique
        • 10.3.5.2.2.3. France Clinical Chemistry Market, By Technique
        • 10.3.5.2.3 France In Vitro Diagnostic (IVD) Market, By Application
        • 10.3.5.2.4 France In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.3.5.3 UK
        • 10.3.5.3.1 UK In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.3.5.3.2 UK In Vitro Diagnostic (IVD) Market, By Technique
        • 10.3.5.3.2.1. UK Immunodiagnostics Market, By Technique
        • 10.3.5.3.2.2. UK Molecular Diagnostics Market, By Technique
        • 10.3.5.3.2.3. UK Clinical Chemistry Market, By Technique
        • 10.3.5.3.3 UK In Vitro Diagnostic (IVD) Market, By Application
        • 10.3.5.3.4 UK In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.3.5.4 Italy
        • 10.3.5.4.1 Italy In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.3.5.4.2 Italy In Vitro Diagnostic (IVD) Market, By Technique
        • 10.3.5.4.2.1. Italy Immunodiagnostics Market, By Technique
        • 10.3.5.4.2.2. Italy Molecular Diagnostics Market, By Technique
        • 10.3.5.4.2.3. Italy Clinical Chemistry Market, By Technique
        • 10.3.5.4.3 Italy In Vitro Diagnostic (IVD) Market, By Application
        • 10.3.5.4.4 Italy In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.3.5.5 Spain
        • 10.3.5.5.1 Spain In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.3.5.5.2 Spain In Vitro Diagnostic (IVD) Market, By Technique
        • 10.3.5.5.2.1. Spain Immunodiagnostics Market, By Technique
        • 10.3.5.5.2.2. Spain Molecular Diagnostics Market, By Technique
        • 10.3.5.5.2.3. Spain Clinical Chemistry Market, By Technique
        • 10.3.5.5.3 Spain In Vitro Diagnostic (IVD) Market, By Application
        • 10.3.5.5.4 Spain In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.3.5.6 Rest of Europe
        • 10.3.5.6.1 Rest of Europe In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.3.5.6.2 Rest of Europe In Vitro Diagnostic (IVD) Market, By Technique
        • 10.3.5.6.2.1. Rest of Europe Immunodiagnostics Market, By Technique
        • 10.3.5.6.2.2. Rest of Europe Molecular Diagnostics Market, By Technique
        • 10.3.5.6.2.3. Rest of Europe Clinical Chemistry Market, By Technique
        • 10.3.5.6.3 Rest of Europe In Vitro Diagnostic (IVD) Market, By Application
        • 10.3.5.6.4 Rest of Europe In Vitro Diagnostic (IVD) Market, By Enduser
  • 10.4. ASIA-PACIFIC
    • 10.4.1 ASIA-PACIFIC IN VITRO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE
    • 10.4.2 ASIA-PACIFIC IN VITRO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE
      • 10.4.2.1 Asia-Pacific Immunodiagnostics Market, By Technique
      • 10.4.2.2 Asia-Pacific Molecular Diagnostics Market, By Technique
      • 10.4.2.3 Asia-Pacific Clinical Chemistry Market, By Technique
    • 10.4.3 ASIA-PACIFIC IN VITRO DIAGNOSTIC (IVD) MARKET, BY APPLICATION
    • 10.4.4 ASIA-PACIFIC IN VITRO DIAGNOSTIC (IVD) MARKET, BY ENDUSER
    • 10.4.5 ASIA-PACIFIC IN VITRO DIAGNOSTIC (IVD) MARKET, BY COUNTRY
      • 10.4.5.1 India
        • 10.4.5.1.1 India In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.4.5.1.2 India In Vitro Diagnostic (IVD) Market, By Technique
        • 10.4.5.1.2.1. India Immunodiagnostics Market, By Technique
        • 10.4.5.1.2.2. India Molecular Diagnostics Market, By Technique
        • 10.4.5.1.2.3. India Clinical Chemistry Market, By Technique
        • 10.4.5.1.3 India In Vitro Diagnostic (IVD) Market, By Application
        • 10.4.5.1.4 India In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.4.5.2 China
        • 10.4.5.2.1 China In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.4.5.2.2 China In Vitro Diagnostic (IVD) Market, By Technique
        • 10.4.5.2.2.1. China Immunodiagnostics Market, By Technique
        • 10.4.5.2.2.2. China Molecular Diagnostics Market, By Technique
        • 10.4.5.2.2.3. China Clinical Chemistry Market, By Technique
        • 10.4.5.2.3 China In Vitro Diagnostic (IVD) Market, By Application
        • 10.4.5.2.4 China In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.4.5.3 Japan
        • 10.4.5.3.1 Japan In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.4.5.3.2 Japan In Vitro Diagnostic (IVD) Market, By Technique
        • 10.4.5.3.2.1. Japan Immunodiagnostics Market, By Technique
        • 10.4.5.3.2.2. Japan Molecular Diagnostics Market, By Technique
        • 10.4.5.3.2.3. Japan Clinical Chemistry Market, By Technique
        • 10.4.5.3.3 Japan In Vitro Diagnostic (IVD) Market, By Application
        • 10.4.5.3.4 Japan In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.4.5.4 Australia
        • 10.4.5.4.1 Australia In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.4.5.4.2 Australia In Vitro Diagnostic (IVD) Market, By Technique
        • 10.4.5.4.2.1. Australia Immunodiagnostics Market, By Technique
        • 10.4.5.4.2.2. Australia Molecular Diagnostics Market, By Technique
        • 10.4.5.4.2.3. Australia Clinical Chemistry Market, By Technique
        • 10.4.5.4.3 Australia In Vitro Diagnostic (IVD) Market, By Application
        • 10.4.5.4.4 Australia In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.4.5.5 South Korea
        • 10.4.5.5.1 South Korea In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.4.5.5.2 South Korea In Vitro Diagnostic (IVD) Market, By Technique
        • 10.4.5.5.2.1. South Korea Immunodiagnostics Market, By Technique
        • 10.4.5.5.2.2. South Korea Molecular Diagnostics Market, By Technique
        • 10.4.5.5.2.3. South Korea Clinical Chemistry Market, By Technique
        • 10.4.5.5.3 South Korea In Vitro Diagnostic (IVD) Market, By Application
        • 10.4.5.5.4 South Korea In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.4.5.6 Rest of Asia-Pacific
        • 10.4.5.6.1 Rest of Asia-Pacific In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.4.5.6.2 Rest of Asia-Pacific In Vitro Diagnostic (IVD) Market, By Technique
        • 10.4.5.6.2.1. Rest of Asia-Pacific Immunodiagnostics Market, By Technique
        • 10.4.5.6.2.2. Rest of Asia-Pacific Molecular Diagnostics Market, By Technique
        • 10.4.5.6.2.3. Rest of Asia-Pacific Clinical Chemistry Market, By Technique
        • 10.4.5.6.3 Rest of Asia-Pacific In Vitro Diagnostic (IVD) Market, By Application
        • 10.4.5.6.4 Rest of Asia-Pacific In Vitro Diagnostic (IVD) Market, By Enduser
  • 10.5. REST OF WORLD
    • 10.5.1 REST OF WORLD IN VITRO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE
    • 10.5.2 REST OF WORLD IN VITRO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE
      • 10.5.2.1 Rest of World Immunodiagnostics Market, By Technique
      • 10.5.2.2 Rest of World Molecular Diagnostics Market, By Technique
      • 10.5.2.3 Rest of World Clinical Chemistry Market, By Technique
    • 10.5.3 REST OF WORLD IN VITRO DIAGNOSTIC (IVD) MARKET, BY APPLICATION
    • 10.5.4 REST OF WORLD IN VITRO DIAGNOSTIC (IVD) MARKET, BY ENDUSER
    • 10.5.5 REST OF WORLD IN VITRO DIAGNOSTIC (IVD) MARKET, BY COUNTRY
      • 10.5.5.1 Latin America
        • 10.5.5.1.1 Latin America In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.5.5.1.2 Latin America In Vitro Diagnostic (IVD) Market, By Technique
        • 10.5.5.1.2.1. Latin America Immunodiagnostics Market, By Technique
        • 10.5.5.1.2.2. Latin America Molecular Diagnostics Market, By Technique
        • 10.5.5.1.2.3. Latin America Clinical Chemistry Market, By Technique
        • 10.5.5.1.3 Latin America In Vitro Diagnostic (IVD) Market, By Application
        • 10.5.5.1.4 Latin America In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.5.5.2 Middle East
        • 10.5.5.2.1 Middle East In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.5.5.2.2 Middle East In Vitro Diagnostic (IVD) Market, By Technique
        • 10.5.5.2.2.1. Middle East Immunodiagnostics Market, By Technique
        • 10.5.5.2.2.2. Middle East Molecular Diagnostics Market, By Technique
        • 10.5.5.2.2.3. Middle East Clinical Chemistry Market, By Technique
        • 10.5.5.2.3 Middle East In Vitro Diagnostic (IVD) Market, By Application
        • 10.5.5.2.4 Middle East In Vitro Diagnostic (IVD) Market, By Enduser
      • 10.5.5.3 Africa
        • 10.5.5.3.1 Africa In Vitro Diagnostic (IVD) Market, By Product Type
        • 10.5.5.3.2 Africa In Vitro Diagnostic (IVD) Market, By Technique
        • 10.5.5.3.2.1. Africa Immunodiagnostics Market, By Technique
        • 10.5.5.3.2.2. Africa Molecular Diagnostics Market, By Technique
        • 10.5.5.3.2.3. Africa Clinical Chemistry Market, By Technique
        • 10.5.5.3.3 Africa In Vitro Diagnostic (IVD) Market, By Application
        • 10.5.5.3.4 Africa In Vitro Diagnostic (IVD) Market, By Enduser

11. COMPANY PROFILES

  • 11.1. BIOMERIEUX
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 COMPANY SNAPSHOT
    • 11.1.3 OPERATING BUSINESS SEGMENTS
    • 11.1.4 BUSINESS PERFORMANCE
    • 11.1.5 SALES BY BUSINESS SEGMENT
    • 11.1.6 SALES BY GEOGRAPHIC SEGMENT
    • 11.1.7 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 11.1.8 PRIMARY MARKET COMPETITORS
  • 11.2. SYSMEX CORPORATION
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 COMPANY SNAPSHOT
    • 11.2.3 OPERATING BUSINESS SEGMENTS
    • 11.2.4 BUSINESS PERFORMANCE
    • 11.2.5 SALES BY GEOGRAPHIC SEGMENT
    • 11.2.6 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 11.2.7 PRIMARY MARKET COMPETITORS
  • 11.3. QIAGEN N.V.
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 COMPANY SNAPSHOT
    • 11.3.3 OPERATING BUSINESS SEGMENTS
    • 11.3.4 BUSINESS PERFORMANCE
    • 11.3.5 SALES BY BUSINESS SEGMENT
    • 11.3.6 SALES BY GEOGRAPHIC SEGMENT
    • 11.3.7 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 11.3.8 PRIMARY MARKET COMPETITORS
  • 11.4. BIO-RAD LABORATORIES, INC.
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 COMPANY SNAPSHOT
    • 11.4.3 OPERATING BUSINESS SEGMENTS
    • 11.4.4 BUSINESS PERFORMANCE
    • 11.4.5 SALES BY BUSINESS SEGMENT
    • 11.4.6 SALES BY GEOGRAPHIC SEGMENT
    • 11.4.7 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 11.4.8 PRIMARY MARKET COMPETITORS
  • 11.5. BECTON, DICKINSON AND COMPANY
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 COMPANY SNAPSHOT
    • 11.5.3 OPERATING BUSINESS SEGMENTS
    • 11.5.4 BUSINESS PERFORMANCE
    • 11.5.5 SALES BY BUSINESS SEGMENT
    • 11.5.6 SALES BY GEOGRAPHIC SEGMENT
    • 11.5.7 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 11.5.8 PRIMARY MARKET COMPETITORS
  • 11.6. ROCHE HOLDING
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 COMPANY SNAPSHOT
    • 11.6.3 OPERATING BUSINESS SEGMENTS
    • 11.6.4 BUSINESS PERFORMANCE
    • 11.6.5 SALES BY BUSINESS SEGMENT
    • 11.6.6 SALES BY GEOGRAPHIC SEGMENT
    • 11.6.7 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 11.6.8 PRIMARY MARKET COMPETITORS
  • 11.7. ABBOTT
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 COMPANY SNAPSHOT
    • 11.7.3 OPERATING BUSINESS SEGMENTS
    • 11.7.4 BUSINESS PERFORMANCE
    • 11.7.5 SALES BY BUSINESS SEGMENT
    • 11.7.6 SALES BY GEOGRAPHIC SEGMENT
    • 11.7.7 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 11.7.8 PRIMARY MARKET COMPETITORS
  • 11.8. DANAHER
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 COMPANY SNAPSHOT
    • 11.8.3 OPERATING BUSINESS SEGMENTS
    • 11.8.4 BUSINESS PERFORMANCE
    • 11.8.5 SALES BY BUSINESS SEGMENT
    • 11.8.6 SALES BY GEOGRAPHIC SEGMENT
    • 11.8.7 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 11.8.8 PRIMARY MARKET COMPETITORS
  • 11.9. SIEMENS HEALTHINEERS
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 COMPANY SNAPSHOT
    • 11.9.3 OPERATING BUSINESS SEGMENTS
    • 11.9.4 BUSINESS PERFORMANCE
    • 11.9.5 SALES BY BUSINESS SEGMENT
    • 11.9.6 SALES BY GEOGRAPHIC SEGMENT
    • 11.9.7 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 11.9.8 PRIMARY MARKET COMPETITORS
  • 11.10. THERMO FISHER SCIENTIFIC INC.
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 COMPANY SNAPSHOT
    • 11.10.3 OPERATING BUSINESS SEGMENTS
    • 11.10.4 BUSINESS PERFORMANCE
    • 11.10.5 SALES BY BUSINESS SEGMENT
    • 11.10.6 SALES BY GEOGRAPHIC SEGMENT
    • 11.10.7 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 11.10.8 PRIMARY MARKET COMPETITORS